Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,009 | -8,914 | -6,403 | -4,496 | -2,051 |
| Depreciation Amortization | 7 | 27 | 21 | 14 | 7 |
| Accounts payable and accrued liabilities | 217 | -206 | 236 | 45 | -159 |
| Other Working Capital | -740 | -6 | -156 | -462 | -979 |
| Other Operating Activity | 310 | 829 | -2 | 184 | 387 |
| Operating Cash Flow | $-3,215 | $-8,270 | $-6,303 | $-4,714 | $-2,794 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -72 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-72 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,700 | 12,471 | 12,512 | 3,389 | N/A |
| Financing Cash Flow | $6,700 | $12,471 | $12,512 | $3,389 | $N/A |
| Beginning Cash Position | 10,700 | 6,499 | 6,499 | 6,499 | 6,499 |
| End Cash Position | 14,113 | 10,700 | 12,709 | 5,174 | 3,705 |
| Net Cash Flow | $3,413 | $4,201 | $6,210 | $-1,325 | $-2,794 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,215 | -8,270 | -6,303 | -4,714 | -2,794 |
| Capital Expenditure | -72 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -3,287 | -8,270 | -6,303 | -4,714 | -2,794 |